330792-81-9Relevant articles and documents
Pyrazolo[3,4-d]pyrimidines containing an extended 3-substituent as potent inhibitors of Lck -- a selectivity insight.
Burchat, Andrew F,Calderwood, David J,Friedman, Michael M,Hirst, Gavin C,Li, Biqin,Rafferty, Paul,Ritter, Kurt,Skinner, Barbara S
, p. 1687 - 1690 (2007/10/03)
A series of para-substituted 3-phenyl pyrazolopyrimidines was synthesized and evaluated as inhibitors of lck. The nature of the substitution affected enzyme selectivity and potency for lck, src, kdr, and tie-2. The para-phenoxyphenyl analogue 2 is an orally active lck inhibitor with a bioavailability of 69% and exhibits an extended duration of action in animal models of T cell inhibition.